Cellular and Molecular Neurobiology

, Volume 27, Issue 3, pp 351–358 | Cite as

Hippocampal CA1 Pyramidal Cell Size is Reduced in Bipolar Disorder

  • Lusha Liu
  • S. Charles Schulz
  • Susanne Lee
  • Teri J. Reutiman
  • S. Hossein Fatemi

1. Schizophrenia and bipolar disorder are neurodevelopmental disorders with significant genetic vulnerabilities. Several trophic genes and/or proteins have been implicated in the causation for both disorders.

2. We hypothesized that these genes and/or proteins may impact neuronal growth in both disorders.

3. Hippocampal tissue sections from CA1 area of schizophrenic, bipolar, depressed, and controls subjects, matched for age, sex, PMI, drug exposure, and brain pH were prepared for cell size determination using the Stanley Medical Research Foundation postmortem brain collection.

4. Quantification of hippocampal CA1 pyramidal neuron size showed a significant 12% reduction in cell size (p < 0.05) in bipolar subjects vs. controls. There were nonsignificant trends for reduction in cell size in both schizophrenic and depressed subjects vs. controls.

5. These results indicate for the first time that pyramidal cell atrophy is present in hippocampus of subjects with bipolar disorder.


schizophrenia hippocampus bipolar disorder pyramidal cell size Reelin Bcl-2 DISC1 major depression 


  1. Araghi-Niknam, M., and Fatemi, S. H. (2003). Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell. Mol. Neurobiol. 23:945–952.PubMedCrossRefGoogle Scholar
  2. Benes, F. M., Sorensen, I., and Bird, E. D. (1991). Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr. Bull. 17:597–608.PubMedGoogle Scholar
  3. Burdick, K. E., Hodgkinson, C. A., Szeszko, P. R., Lencz, T., Ekholm, J. M., Kane, J. M., Goldman, D., and Malhotra, A. K. (2005). DISC1 and neurocognitive function in schizophrenia. Neuroreport 16:1399–1402.PubMedCrossRefGoogle Scholar
  4. Chana, G., Landau, S., Beasley, C., Everall, I. P., and Cotter, D. (2003). Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: Evidence for decreased neuronal somal size and increased neuronal density. Biol. Psychiatry 53:1086–1098.PubMedCrossRefGoogle Scholar
  5. Chen, D. F., Schneider, G. E., Martinou, J. C., and Tonegawa, S. (2001). Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385:434–439.CrossRefGoogle Scholar
  6. Fatemi, S. H. (2001). Reelin mutations in mouse and man: From reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol. Psychiatry 6:129–133.PubMedCrossRefGoogle Scholar
  7. Fatemi, S. H. (2005). Reelin glycoprotein: Structure, biology and roles in health and disease. Mol. Psychiatry 10:251–257.PubMedCrossRefGoogle Scholar
  8. Fatemi, S. H., Earle, J. A., and McMenomy, T. (2000). Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 5:654–663, 571.PubMedCrossRefGoogle Scholar
  9. Fatemi, S. H., Halt, A. R., Realmuto, G., Earle, J., Kist, D. A., Thuras, P., and Merz, A. (2002). Purkinje cell size is reduced in cerebellum of patients with autism. Cell. Mol. Neurobiol. 22:171–175.PubMedCrossRefGoogle Scholar
  10. Friedman, L., Findling, R. L., Kenny, J. T., Swales, T. P., Stuve, T. A., Jesberger, J. A., Lewin, J. S., and Schulz, S. C. (1999). An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects. Biol. Psychiatry 46:78–88.PubMedCrossRefGoogle Scholar
  11. Guidotti, A., Auta, J., Davis, J. M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., Uzunov, D., and Costa, E. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57:1061–1069.PubMedCrossRefGoogle Scholar
  12. Jarskog, L. F., and Gilmore, J. H. (2000). Developmental expression of Bcl-2 protein in human cortex. Brain Res. Dev. Brain Res. 119:225–230.PubMedCrossRefGoogle Scholar
  13. Jarskog, L. F., Gilmore, J. H., Selinger, E. S., and Lieberman, J. A. (2000). Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol. Psychiatry 48:641–650.PubMedCrossRefGoogle Scholar
  14. Jarskog, L. F., Selinger, E. S., Lieberman, J. A., and Gilmore, J. M (2004). Apoptotic proteins in the temporal cortex in schizophrenia: High Bax/Bcl2 ratio without caspase-3 activation. Am. J. Pscyhiatry 161:109–115.CrossRefGoogle Scholar
  15. Jarskog, L. F. (2006). Apoptosis in schizophrenia: Pathophysiologic and therapeutic considerations. Curr. Opin. Psychiatry 19:307–312.PubMedCrossRefGoogle Scholar
  16. Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M., Ross, C. A., Hatten, M. E., Nakajima, K., and Sawa, A. (2005). A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell. Biol. 7:1067–1078.CrossRefGoogle Scholar
  17. Sawa, A., and Snyder, S. H. (2005). Genetics. Two genes link two distinct psychoses. Science 310:1187–1191.CrossRefGoogle Scholar
  18. Thomson, P. A., Harris, S. E., Starr, J. M., Whalley, L. J., Porteous, D. J., and Deary, I. J. (2005). Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci. Lett. 389:41–45.PubMedCrossRefGoogle Scholar
  19. Torrey, E. F., Webster, M., Knable, M., Johnston, N., and Yolken, R. H. (2000). The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44:151–155.PubMedCrossRefGoogle Scholar
  20. Zhong, L. T., Sarafian, T., Kane, D. J., Charles, A. C., Mah, S. P., Edwards, R. H., and Bredesen, D. E. (1993). Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. U.S.A. 90:4533–4537.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Lusha Liu
    • 1
  • S. Charles Schulz
    • 1
  • Susanne Lee
    • 1
  • Teri J. Reutiman
    • 1
  • S. Hossein Fatemi
    • 1
    • 2
  1. 1.Department of PsychiatryUniversity of MinnesotaMinneapolisUSA
  2. 2.Division of Neuroscience Research, Department of PsychiatryUniversity of Minnesota Medical SchoolMinneapolisUSA

Personalised recommendations